SUPPORT FOR THE CONDUCT OF STUDIES TO EVALUATE THE TOXICOLOGIC POTENTIAL OF Garcinia cambogia FOR THE NTP
支持开展研究以评估藤黄果对 NTP 的毒理学潜力
基本信息
- 批准号:10213574
- 负责人:
- 金额:$ 70万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-26 至 2020-09-25
- 项目状态:已结题
- 来源:
- 关键词:Amniotic FluidBody Weight decreasedBolus InfusionCytologyDataDesire for foodDietDoseEphedraEvaluationFetusFoodFruitGarciniaGarcinia cambogiaLaboratoriesLipidsMusOralPersonsPlasmaPregnancyRattusRegimenReportingRouteSamplingSperm Count ProcedureSperm MotilityTestingThermogenesisTimeTissuesToxic effectToxicologyVaginabasedietary supplementsexposed human populationfat burningsperm analysis
项目摘要
Garcinia cambogia extract (GCE) was nominated for testing based on its widespread use as a diet aid and a lack of adequate toxicity data. It was the 6th best-selling dietary supplement in the U.S. in 2016 (Smith et al., 2017). GCE is prepared from the rind of Garcinia gummi-gutta (renamed from Garcinia cambogia) fruit and products containing GCE are marketed as ephedra-free diet aids. Purported effects of GCE include appetite suppression, inhibition of lipid synthesis, and fat burning via thermogenesis. Typically, the use of GCE as a weight loss supplement is via caplets taken prior to meals three times per day, resulting in a total dose of approximately 4,500-6,000 mg/day (~75-100 mg/kg/day for a 60 kg person). Due to the recommended regimen of GCE (3 times daily with food) as well as the traditional use of Garcinia as an ingredient in Indian cuisine, dosed-feed was selected as the route of administration, as opposed to oral gavage, which has typically been employed with herbal test articles and delivers a daily bolus dose. During the current year, the draft laboratory reports of the study were prepared and reviewed, and the reports are currently being finalized
藤黄果提取物(GCE)被提名为基于其广泛用作饮食援助和缺乏足够毒性数据的测试。这是2016年美国第六种最畅销的饮食补充剂(Smith等,2017)。 GCE是由藤黄果(Garcinia Gummi-Gutta)(从藤黄果更名)的水果的果皮中制备的,含有GCE的产品被销售为无麻质的饮食辅助工具。 GCE的据称作用包括食欲抑制,抑制脂质合成以及通过热生成燃烧脂肪。通常,将GCE用作减肥补充剂的使用是每天三次在饭前服用的囊,导致总剂量约为4,500-6,000 mg/天(60公斤人群约75-100 mg/kg/kg/kg/kg/kg/kg/kg)。由于推荐的GCE方案(每天使用食物3次)以及藤黄作为印度美食的一种成分,因此被选为剂量喂食作为给药途径,而不是口服饲料,而口服饲料通常是在草药测试中使用的,并每天递送大量的大球剂量。在本年度,准备和审查了研究草案,目前正在确定报告
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BARNEY SPARROW其他文献
BARNEY SPARROW的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BARNEY SPARROW', 18)}}的其他基金
Production of TempOSeq data for the DrugMatrix reference library
为 DrugMatrix 参考库生成 TempOSeq 数据
- 批准号:
10710454 - 财政年份:2017
- 资助金额:
$ 70万 - 项目类别:
Systematic Evaluation of the Application of Zebrafish in Toxicology (SEAZIT) Phase 2
斑马鱼毒理学应用的系统评价 (SEAZIT) 第 2 阶段
- 批准号:
10213572 - 财政年份:2017
- 资助金额:
$ 70万 - 项目类别:
Support for the CONDUCT OF STUDIES TO EVALUATE THE IMPACT OF GENETIC BACKGROUND AND POTENTIAL TREATMENTS ON SEVERE SARS-CoV-2 INDUCED PNEUMONIA FOR THE NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIEN
支持国家环境卫生科学研究所开展研究,评估遗传背景和潜在治疗方法对严重 SARS-CoV-2 引起的肺炎的影响
- 批准号:
10281194 - 财政年份:2017
- 资助金额:
$ 70万 - 项目类别:
Evaluation of HepaRG cells as a screen for chemical toxicity and assay optimization
评估 HepaRG 细胞作为化学毒性筛选和测定优化的作用
- 批准号:
10700772 - 财政年份:2017
- 资助金额:
$ 70万 - 项目类别:
Evaluation of multiple test agents for functional cardiovascular changes in rats
多种测试药物对大鼠功能性心血管变化的评价
- 批准号:
10932828 - 财政年份:2017
- 资助金额:
$ 70万 - 项目类别:
SUPPORT FOR THE CONDUCT OF STUDIES TO EVALUATE TOXICOGENOMIC RESPONSE OF DO MOUSE CELL LINES EXPOSED TO CHEMICALS FOR THE NTP
支持开展研究以评估暴露于 NTP 化学品的 DO 小鼠细胞系的毒理学反应
- 批准号:
10026342 - 财政年份:2017
- 资助金额:
$ 70万 - 项目类别:
NTP Study Conducted at NIOSH- Evaluation of the Subchronic Toxicity of a Satratoxin Producing Chemotype Strain of Stachybotrys Chartarum
NIOSH 进行的 NTP 研究 - 产 Satratoxin 的 Stachybotrys Chartarum 化学型菌株的亚慢性毒性评估
- 批准号:
9795258 - 财政年份:2017
- 资助金额:
$ 70万 - 项目类别:
Support for the Conduct of Studies to Evaluate the Impact of Genetic Background and Potential Treatments of SARS-CoV-2 Induced Pneumonia
支持开展研究以评估遗传背景的影响和 SARS-CoV-2 引起的肺炎的潜在治疗方法
- 批准号:
10700771 - 财政年份:2017
- 资助金额:
$ 70万 - 项目类别:
Evaluation of multiple test agents for functional cardiovascular changes in rats
多种测试药物对大鼠功能性心血管变化的评价
- 批准号:
10710453 - 财政年份:2017
- 资助金额:
$ 70万 - 项目类别:
Evaluation and use of 2D and 3D HepaRG cells to screen for chemical toxicity
评估和使用 2D 和 3D HepaRG 细胞筛选化学毒性
- 批准号:
10932826 - 财政年份:2017
- 资助金额:
$ 70万 - 项目类别:
相似国自然基金
针刺减少罗格列酮所致体重增加效应及其基于PPAR-γ的中枢调节机制
- 批准号:81303018
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Glucagon Pump Therapy for Post-Bariatric Hypoglycemia: Merging Physiology and Engineering
胰高血糖素泵治疗减肥后低血糖:生理学与工程学的结合
- 批准号:
10754041 - 财政年份:2023
- 资助金额:
$ 70万 - 项目类别:
Alleviating carbohydrate counting in adults with type 1 diabetes with weekly Semaglutide injections added to an automated insulin delivery with Lyumjev
通过每周注射索马鲁肽并添加 Lyumjev 自动胰岛素输送来减少 1 型糖尿病成人患者的碳水化合物计数
- 批准号:
10636689 - 财政年份:2023
- 资助金额:
$ 70万 - 项目类别:
Targeted neuromodulation strategies to delay hypoglossal motoneuron death and preserve tongue strength, function, and structure in a mouse model of ALS
延缓 ALS 小鼠模型舌下运动神经元死亡并保持舌头力量、功能和结构的靶向神经调节策略
- 批准号:
10527999 - 财政年份:2022
- 资助金额:
$ 70万 - 项目类别:
Deglutitive and airway protective functions of proximal/ striated muscle esophagus in health and disease
近端/横纹肌食管在健康和疾病中的吞咽和气道保护功能
- 批准号:
10611445 - 财政年份:2022
- 资助金额:
$ 70万 - 项目类别: